Case and Research Letters
Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib
Leído
5387
Vecesse ha leído el artículo
1903
Total PDF
3484
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S1578219019302811" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.05.039" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2230" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:863-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731019302133" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.05.022" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2230" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:863-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 288 "formatos" => array:2 [ "HTML" => 216 "PDF" => 72 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Carcinoma basocelular agresivo del párpado inferior: ventaja del vismodegib neoadyuvante" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "863" "paginaFinal" => "865" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 659 "Ancho" => 1505 "Tamanyo" => 218427 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Etapas intraoperatorias con escisión de la lesión residual sospechada en el párpado inferior y reconstrucción con un colgajo de Tripier modificado del párpado superior (A, B) y resultado posquirúrgico a los 6 meses (C).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A.F. Monteiro, M. Rato, M. Trigo, C. Martins" "autores" => array:4 [ 0 => array:2 [ "nombre" => "A.F." "apellidos" => "Monteiro" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Rato" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Trigo" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Martins" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219019302811" "doi" => "10.1016/j.adengl.2018.05.039" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302811?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019302133?idApp=UINPBA000044" "url" => "/00017310/0000011000000010/v1_201912070749/S0001731019302133/v1_201912070749/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219019303038" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.06.028" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2218" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:865-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Rheumatoid Nodulosis in an Adult Patient Negative for Rheumatoid Factor" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "865" "paginaFinal" => "867" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nodulosis reumatoideos en una paciente adulta con factor reumatoide negativo" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 850 "Ancho" => 1506 "Tamanyo" => 363126 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A, Panoramic image showing granulomas located in the deep dermis (hematoxylin-eosin, original magnification ×20). B, Detail of the same image showing granulomas composed of palisaded histiocytes (arrow) arranged around a central eosinophilic zone corresponding to fibrin (asterisk) (hematoxylin-eosin, original magnification ×100).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P.J. Álvarez-Chinchilla, I. Poveda Montoyo, F. Illán, J. Bañuls Roca" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P.J." "apellidos" => "Álvarez-Chinchilla" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Poveda Montoyo" ] 2 => array:2 [ "nombre" => "F." "apellidos" => "Illán" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Bañuls Roca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731019301838" "doi" => "10.1016/j.ad.2018.06.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301838?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303038?idApp=UINPBA000044" "url" => "/15782190/0000011000000010/v1_201912080808/S1578219019303038/v1_201912080808/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219019303014" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.01.008" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2105" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2019;110:e1-e2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">e-Images in Dermatology</span>" "titulo" => "Squamous Cell Carcinoma on a Port Wine Stain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e1" "paginaFinal" => "e2" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma epidermoide sobre mancha en vino de Oporto" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 689 "Ancho" => 906 "Tamanyo" => 67971 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Oscoz-Jaime, M. Azcona-Rodríguez, J.I. Yanguas-Bayona" "autores" => array:3 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Oscoz-Jaime" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Azcona-Rodríguez" ] 2 => array:2 [ "nombre" => "J.I." "apellidos" => "Yanguas-Bayona" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018305027" "doi" => "10.1016/j.ad.2018.01.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305027?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303014?idApp=UINPBA000044" "url" => "/15782190/0000011000000010/v1_201912080808/S1578219019303014/v1_201912080808/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib" "subtitulo" => "[[es]]Carcinoma basocelular agresivo del párpado inferior: ventaja del vismodegib neoadyuvante" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "863" "paginaFinal" => "865" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ana Filipe Monteiro, Margarida Rato, Miguel Trigo, César Martins" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Ana Filipe" "apellidos" => "Monteiro" "email" => array:1 [ 0 => "anafilipemonteiro@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:4 [ "nombre" => "Margarida" "apellidos" => "Rato" "email" => array:1 [ 0 => "margaridagaiorato@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:4 [ "nombre" => "Miguel" "apellidos" => "Trigo" "email" => array:1 [ 0 => "trigo75@live.com.pt" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:4 [ "nombre" => "César" "apellidos" => "Martins" "email" => array:1 [ 0 => "wmed.medicos@sapo.pt" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Dermatology Department, Hospital de Santarém EPE, Santarém, Portugal, Avenida Bernardo Santareno, 2005-177 Santarém, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Plastic Surgery Department, Centro Hospitalar de Lisboa Ocidental EPE, Estrada do Forte do Alto do Duque, 1449-005 Lisboa, Portugal" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 657 "Ancho" => 1505 "Tamanyo" => 204106 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0190" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Intraoperative stages with excision of the residual suspected lesion in the lower eyelid and reconstruction with a modified Tripier flap of the upper eyelid (A,B) and 6-month postoperative result (C).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">To the Editor:</p><p id="par0010" class="elsevierStylePara elsevierViewall">Basal cell carcinoma (BCC) is the most common skin cancer and represents 90% of malignant eyelid tumors.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Management options are mainly surgical, including Mohs micrographic surgery and wide surgical excision.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, some of these lesions can progress to an advanced locally stage and represent a therapeutic challenge. In 2012 the US Food and Drug Administration (FDA) approved Vismodegib, an oral hedgehog pathway inhibitor, for the treatment of locally advanced and metastatic BCCs which are inappropriate for surgery or radiotherapy.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> Herein, we report a patient with an infraorbital locally advanced BCC who was offered oral vismodegib before surgery reducing surgery-associated morbidity and allowing the preservation of functional and aesthetic aspect of the affected area.</p><p id="par0015" class="elsevierStylePara elsevierViewall">A 81-year-old man presented with a 6-year history of a progressively growing lesion in the left lower eyelid. Examination of the ocular adnexae showed an extensive, infiltrated and centrally erosive lesion, covered by a crust with 6<span class="elsevierStyleHsp" style=""></span>cm of major axis and involving all the left lower eyelid with ectropion and extending onto the left malar cheek (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Biopsy showed a ulcerated BCC and computed tomography (CT) scan of the head did not identify alterations in the facial bones (left maxilla, inferior orbital rim, and base of the nasal bone). Due to the advanced nature of the lesion and involvement of more than two-thirds of the tarsal conjunctiva with a complex location for surgery and radiotherapy, the patient was offered oral vismodegib 150<span class="elsevierStyleHsp" style=""></span>mg PO daily in order to shrink the tumor before surgery and reduce surgery-associated morbidity.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">The reassessment was performed at 4, 8 and 16 weeks after initiation of oral therapy (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). At 16 weeks the lesion showed a significant clinical improvement with substantial regression and a biopsy of the tarsal conjunctiva was performed. The histopathologic examination of the tarsal conjunctiva was compatible with “absence of neoplasia”. Vismodegib treatment was discontinued at 23 weeks and wide excision of the residual lesion with reconstruction was performed. The pre-surgical clinically visible lesion size was 2,5<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>0,8<span class="elsevierStyleHsp" style=""></span>cm and the final surgical defect measured 3,2<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>1,5<span class="elsevierStyleHsp" style=""></span>cm. For the reconstruction of the defect, it was suggested to perform a modified Tripier flap (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A). A single pedicle, randomized and lateral, was drawn with a relatively wide base (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B). The surgical solution was consistent with a good functional result. Histological evaluation of the surgical specimen revealed “absence of neoplasia”. The follow-up 6 months after surgery revealed no recurrences and an excellent functional and aesthetic result (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>C). The patient tolerated vismodegib very well just reporting a slight muscles spasm, dysgeusia and alopecia of the eyebrows and eyelids. All the side effects were graded as 1 using the Common Terminology Criteria for Adverse Events (CTCAE). No severe adverse events were observed.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">It is established that neoadjuvant treatment with vismodegib for an average of 4 months before surgery reduces tumor area and surgical defect size.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a> In literature, a clinical trial with short-term vismodegib showed a reduction of the surgical defect area by 31% if used for at least 3 months in non-recurrent BCCs of functionally sensitive locations.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Furthermore, previous studies revealed that the clinical appearance of tumors after vismodegib was variable and did not predict histologic cure.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,5</span></a> This achievement enhances the importance of performing biopsies or diagnostic techniques such as confocal laser scanning microscopy in order to identify residual tumor nests. The margins performed in this case had the intention to excise the clinical residual lesion with 10<span class="elsevierStyleHsp" style=""></span>mm margin and the reconstruction of the inferior eyelid ectropion. Some studies support the idea that vismodegib “cure” is temporary, as BCCs recur at the same site within a few months of drug discontinuation.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,5</span></a> We consider that probably the best surgical option after vismodegib would be micrographic Mohs surgery (MMS) as this surgical technique allows to localize residual nests of BCC that can remain during the reduction of the tumor.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">In our clinical case, a modified Tripier flap was performed as eyelid wound repair must be carefully designed so that eyelid function is maintained and the globe is protected. The original Tripier flap is considered a myocutaneous bipedicular flap originating from the upper eyelid and recommended for the reconstruction of lower lateral eyelid defects.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Usually this technique is time-consuming and requires a second surgical stage for sectioning the lateral pedicles.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Its modification consists in planning a single pedicle, lateral, randomized in one-stage surgery which does not rely on the inclusion of orbicularis muscle or innervation. The surgical solution of our case demonstrates an option of the lower eyelid reconstruction, simple and versatile without ectropion or eyelid distortion.</p><p id="par0035" class="elsevierStylePara elsevierViewall">This case highlights the potential of short-term vismodegib as neoadjuvant to surgery for high-risk locally advanced basal cell carcinomas, especially in functionally sensitive locations as the periocular and orbital areas.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflicts of interest</span><p id="par0040" class="elsevierStylePara elsevierViewall">Dr. César Martins is a member of the Roche Pharmaceutics Advisory board. The other authors declare no conflicts of interest.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Funding sources</span><p id="par0045" class="elsevierStylePara elsevierViewall">None.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "xpalclavsec1177567" "titulo" => "Palabras clave" ] 1 => array:2 [ "identificador" => "xpalclavsec1177568" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Funding sources" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-01-08" "fechaAceptado" => "2018-05-23" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1177568" "palabras" => array:3 [ 0 => "basal cell carcinoma" 1 => "neoadjuvant therapy" 2 => "vismodegib" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Monteiro AF, Rato M, Trigo M, Martins C. Carcinoma basocelular agresivo del párpado inferior: ventaja del vismodegib neoadyuvante. Actas Dermo-Sifiliográficas. 2019;110:863–865.</p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 567 "Ancho" => 1300 "Tamanyo" => 161748 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0185" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical regression of left lower eyelid basal cell carcinoma during vismodegib therapy.</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 657 "Ancho" => 1505 "Tamanyo" => 204106 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0190" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Intraoperative stages with excision of the residual suspected lesion in the lower eyelid and reconstruction with a modified Tripier flap of the upper eyelid (A,B) and 6-month postoperative result (C).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vismodegib for periocular and orbital basal cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H.S. Gill" 1 => "E.E. Moscato" 2 => "A.L.S. Chang" 3 => "S. Soon" 4 => "R.Z. Silkiss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamaophthalmol.2013.5018" "Revista" => array:5 [ "tituloSerie" => "JAMA Ophthalmol" "fecha" => "2013" "volumen" => "131" "paginaInicial" => "1591" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24136169" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of vismodegib in advanced basal-cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Sekulic" 1 => "M.R. Migden" 2 => "A.E. Oro" 3 => "L. Dirix" 4 => "K.D. Lewis" 5 => "J.D. Hainsworth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1113713" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2012" "volumen" => "366" "paginaInicial" => "2171" "paginaFinal" => "2179" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22670903" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Basal cell skin cancer, Version 1.2016, NCCN clinical practice guidelines in oncology" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.K. Bichakjian" 1 => "T. Olencki" 2 => "S.Z. Aasi" 3 => "M. Alam" 4 => "J.S. Andersen" 5 => "D. Berg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.6004/jnccn.2016.0065" "Revista" => array:6 [ "tituloSerie" => "J Natl Compr Canc Netw" "fecha" => "2016" "volumen" => "14" "paginaInicial" => "574" "paginaFinal" => "597" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27160235" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Z. Apalla" 1 => "C. Papageorgiou" 2 => "A. Lallas" 3 => "E. Sotiriou" 4 => "E. Lazaridou" 5 => "E. Vakirlis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/CCID.S101330" "Revista" => array:6 [ "tituloSerie" => "Clin Cosmet Investig Dermatol" "fecha" => "2017" "volumen" => "10" "paginaInicial" => "171" "paginaFinal" => "177" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28546761" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.S. Ally" 1 => "S. Aasi" 2 => "A. Wysong" 3 => "C. Teng" 4 => "E. Anderson" 5 => "I. Bailey-Healy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.05.020" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2014" "volumen" => "71" "paginaInicial" => "904" "paginaFinal" => "911" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24929884" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Alcalay" 1 => "G. Tauber" 2 => "E. Fenig" 3 => "E. Hodak" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Drugs Dermatol" "fecha" => "2015" "volumen" => "14" "paginaInicial" => "219" "paginaFinal" => "223" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25738842" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tripier flap for medial lower eyelid reconstruction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Bickle" 1 => "R.G. Bennet" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Dermatologic Surg" "fecha" => "2008" "volumen" => "34" "paginaInicial" => "1545" "paginaFinal" => "1548" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Modified tripier flap in reconstruction of the lower eyelid" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W.L.G. Machado" 1 => "M. Gurfinkel PC de" 2 => "G.V. Gualberto" 3 => "F.M.S. Sampaio" 4 => "M.L.C. Melo" 5 => "C.M. Treu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/abd1806-4841.20153373" "Revista" => array:6 [ "tituloSerie" => "An Bras Dermatol" "fecha" => "2015" "volumen" => "90" "paginaInicial" => "108" "paginaFinal" => "110" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26312689" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000010/v1_201912080808/S1578219019302811/v1_201912080808/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000010/v1_201912080808/S1578219019302811/v1_201912080808/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302811?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 7 | 11 | 18 |
| 2024 Octubre | 71 | 44 | 115 |
| 2024 Septiembre | 82 | 33 | 115 |
| 2024 Agosto | 92 | 58 | 150 |
| 2024 Julio | 70 | 29 | 99 |
| 2024 Junio | 101 | 47 | 148 |
| 2024 Mayo | 77 | 33 | 110 |
| 2024 Abril | 71 | 20 | 91 |
| 2024 Marzo | 66 | 40 | 106 |
| 2024 Febrero | 62 | 51 | 113 |
| 2024 Enero | 63 | 39 | 102 |
| 2023 Diciembre | 61 | 23 | 84 |
| 2023 Noviembre | 82 | 42 | 124 |
| 2023 Octubre | 83 | 38 | 121 |
| 2023 Septiembre | 79 | 34 | 113 |
| 2023 Agosto | 45 | 24 | 69 |
| 2023 Julio | 99 | 49 | 148 |
| 2023 Junio | 69 | 30 | 99 |
| 2023 Mayo | 77 | 29 | 106 |
| 2023 Abril | 57 | 26 | 83 |
| 2023 Marzo | 60 | 31 | 91 |
| 2023 Febrero | 71 | 25 | 96 |
| 2023 Enero | 54 | 30 | 84 |
| 2022 Diciembre | 68 | 44 | 112 |
| 2022 Noviembre | 91 | 33 | 124 |
| 2022 Octubre | 54 | 37 | 91 |
| 2022 Septiembre | 48 | 45 | 93 |
| 2022 Agosto | 45 | 45 | 90 |
| 2022 Julio | 64 | 39 | 103 |
| 2022 Junio | 24 | 28 | 52 |
| 2022 Mayo | 79 | 42 | 121 |
| 2022 Abril | 65 | 36 | 101 |
| 2022 Marzo | 72 | 58 | 130 |
| 2022 Febrero | 97 | 38 | 135 |
| 2022 Enero | 84 | 38 | 122 |
| 2021 Diciembre | 57 | 40 | 97 |
| 2021 Noviembre | 55 | 50 | 105 |
| 2021 Octubre | 58 | 51 | 109 |
| 2021 Septiembre | 52 | 38 | 90 |
| 2021 Agosto | 51 | 24 | 75 |
| 2021 Julio | 49 | 27 | 76 |
| 2021 Junio | 47 | 25 | 72 |
| 2021 Mayo | 53 | 35 | 88 |
| 2021 Abril | 182 | 96 | 278 |
| 2021 Marzo | 60 | 32 | 92 |
| 2021 Febrero | 47 | 24 | 71 |
| 2021 Enero | 47 | 23 | 70 |
| 2020 Diciembre | 54 | 14 | 68 |
| 2020 Noviembre | 32 | 15 | 47 |
| 2020 Octubre | 40 | 19 | 59 |
| 2020 Septiembre | 33 | 8 | 41 |
| 2020 Agosto | 22 | 27 | 49 |
| 2020 Julio | 20 | 10 | 30 |
| 2020 Junio | 25 | 20 | 45 |
| 2020 Mayo | 33 | 22 | 55 |
| 2020 Abril | 25 | 18 | 43 |
| 2020 Marzo | 43 | 10 | 53 |
| 2020 Febrero | 8 | 4 | 12 |
| 2020 Enero | 1 | 2 | 3 |
Mostrar todo
